Contribution of duodenal biopsies in pancreatic cancer with duodenal involvement: Single-center experience
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S382
DOI: 10.1055/s-0044-1783642 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von B. Aabdi und 5 weiteren Autor:innen. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
Aims
Pancreatic cancer is a silent killer cancer and the fourth leading cause of cancer-related death with a poor overall survival rate. Most patients with pancreatic carcinoma develop, independently or concomitantly, biliary obstruction and/or direct duodenal invasion during their disease. Detection of pancreatic cancer in duodenal biopsy specimens could be a diagnostic challenge. We investigated a series of duodenal biopsies to identify duodenal wall invasion by pancreatic carcinoma. Furthermore, this study aimed to evaluate duodenal involvement as a prognostic factor for the survival of patients with pancreatic cancer.
Methods
The endoscopic database from the gastroenterology department of our University hospital was reviewed. 214 patients with borderline resectable, locally advanced or metastatic pancreatic cancer were identified between June 2018 and November 2023. Demographic data and pathological features were also taken into account. This database was employed to identify duodenal wall invasion through duodenal biopsies and to evaluate the prognostic impact of duodenal involvement on the overall survival of pancreatic cancer.
Results
Duodenal invasion was suspected in 62 cases (28.9%) among 214 patients with pancreatic cancer who underwent duodenoscopy at diagnosis. The pathological specimens have shown respectively in three cases (0.9%) namely, pancreatic invasion from duodenal adenocarcinoma, duodenal metastasis from lung adenocarcinoma with synchronous benign pancreatic lesion and duodenal metastasis from primary pancreatic adenocarcinoma. These last three cases were excluded from this study. The median age of the selected patients was 68.5 years [IQR: 45-92]. The male/female ratio was 1.29:1. The most common site was head of pancreas (75%). Locally advanced (43.3%) and metastatic (41.6%) cancers were predominant, while borderline resectable tumors were observed only in 3.3% of cases. Among 59 patients (27, 5%) with suspected duodenal involvement, 55 gastroduodenal lesions were identified during duodenoscopy as follows: duodenal invasion (n=53) (90%) and signs of portal hypertension (n=2) (3%). Pathological diagnosis of duodenal invasion was confirmed in 20 patients (34%), adenocarcinoma was the most common type of pancreatic cancer (85%). In 47% of cases, no duodenal invasion was found, and the diagnosis of pancreatic carcinoma was proved by brush cytology during ERCP and/or by Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA). Duodenal wall invasion could not be assessed in seven patients (12%) due to the lack of histological data and/or insufficient samples. In multivariate survival analysis, there was no worsening of overall survival in patients with duodenal invasion. [ 1 ] [ 2 ] [ 3 ]
Conclusions
In this study, the association between duodenal involvement and overall survival could not be established. Our findings concluded that approximately 35% of patients with suspected duodenal involvement have shown duodenal invasion. These outcomes suggested that if duodenal involvement was suspected, duodenal biopsies should be performed. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Aabdi, B., Koulali, H., Zazour, A., Elmqaddem, O., Ismaili, Z., & Ghizlane, K. (2024). Contribution of duodenal biopsies in pancreatic cancer with duodenal involvement: Single-center experience. Endoscopy, 56(S 02 S 02), S382. https://doi.org/10.1055/s-0044-1783642
Vancouver
Aabdi B, Koulali H, Zazour A, Elmqaddem O, Ismaili Z, Ghizlane K. Contribution of duodenal biopsies in pancreatic cancer with duodenal involvement: Single-center experience. Endoscopy. 2024;56(S 02 S 02):S382. doi:10.1055/s-0044-1783642
BibTeX
@article{Aabdi2024,
author = {Aabdi, B. and Koulali, H. and Zazour, A. and Elmqaddem, O. and Ismaili, Z. and Ghizlane, K.},
title = {Contribution of duodenal biopsies in pancreatic cancer with duodenal involvement: Single-center experience},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S382},
doi = {10.1055/s-0044-1783642}
}
EUVIMED